| HOME >> MEDICINE >> TECHNOLOGY |
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
Penicillin 4
Cephalosporins 4
Macrolides 4
Quinolones 4
Carbapenems 4
Other Antibiotics 5
Aminoglycosides 5
Tetracyclines 5
Sulfonamides 5
Mupirocin 5
Glycopeptides 5
Synercid 6
Oxazolidinones 6
Linezolid 6
2. INDUSTRY OVERVIEW 7
Antibiotic Resistance and Generic Competition to Impact Long
Term Growth 7
New Regulations Guiding Usage of Drugs to Drive Growth 7
Current & Future Analysis 7
3. MARKET DYNAMICS 9
Anti-Bacterials Segment Drives Global Anti- Infectives Market 9
Antibiotic Resistance - A Primary Growth Inhibitor 9
Antibiotic-Resistant Bacteria by Type 9
Patent Expiries Commoditize Antibiotics 10
Patent Expiries of Leading Drugs in the Recent Past, Current,
and Future (2000 -2013) 10
Anti-MRSA Antibiotics Find Their Way 10
Table 1: World MRSA Treatments (2007 & 2008) : Percentage
Share Breakdown by Leading Antibiotic Drugs -Vancomycin,
Zyvox, Cubicin and Tygacil (includes corresponding
Graph/Chart) 11
Key Antibiotics in Pipeline 11
4. COMPETITION 12
Highly Competitive Market 12
Table 2: Leading Players in the Worldwide Antibiotics Market
(2008): Percentage Breakdown by Value Sales for Pfizer, Glaxo
Smithkline, Sanofi-aventis, Johnson & Johnson, Bayer, Abbott,
Wyeth, and Others (includes corresponding Graph/Chart) 12
GlaxoSmithKline - The Undisputed Leader of Penicillin Market 13
Table 3: Worldwide Leading Antibiotics within Penicillin
Class (2005 & 2006): Percentage Breakdown by Value for
Augmentin, Zosyn/Tazocin, Amoxil, and Others (includes
corresponding Graph/Chart) 13
GlaxoSmithKline Leads Cephalosporin Market
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |